About 34 percent of uninsured U.S. adults did not take their medication as prescribed in 2017 in order to reduce their prescription drug costs, according to a Centers for Disease Control and Prevention report released today. According to the report, among U.S. adults aged 18-64 who were prescribed medication in the past 12 months, the percentage who did not take their medication as prescribed, asked their doctor for a lower-cost medication, or used alternative therapies to reduce prescription drug costs decreased from 2013 through 2015, and then remained relatively constant from 2015 through 2017. In 2017, strategies for reducing prescription drug costs were most commonly practiced among those who were uninsured, as 39.5 percent asked their doctor for a lower-cost medication and 13.9 percent used alternative therapies. Women were more likely than men to use these strategies, according to the report. 
 
AHA has recommended a number of policy solutions to restrain drug prices, from addressing anticompetitive actions by brand-name drug manufacturers to speeding up generic drug approvals and passing the CREATES Act.
 

Related News Articles

Headline
The median net launch price for 154 new drugs increased 51% between 2022 and 2024, after accounting for inflation and discounts, according to a report released…
Headline
President Trump today announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest paid by…
Headline
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…
Headline
The Department of Health and Human Services today announced prescription drug reforms that will become effective Oct. 1 originating from the Health Data,…
Headline
The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the…
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…